TABLE OF CONTENTS
Volume 37, Issue 3 (February (1) 2006)
Review
Immunity for tumors and microbes after autotransplantation: if you build it, they will (not) come
A P Rapoport
Bone Marrow Transplant 37: 239-247; advance online publication, December 5, 2005; doi:10.1038/sj.bmt.1705242
Special Report
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)
J D Rizzo, J R Wingard, A Tichelli, S J Lee, M T Van Lint, L J Burns, S M Davies, J L M Ferrara and G Socié
Bone Marrow Transplant 37: 249-261; doi:10.1038/sj.bmt.1705243
Original Articles
Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML
B Horn, L-A Baxter-Lowe, L Englert, A McMillan, M Quinn, K DeSantes and M Cowan
Bone Marrow Transplant 37: 263-269; advance online publication, December 5, 2005; doi:10.1038/sj.bmt.1705240
Conditioning Regimens
Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system
B H Kushner, K Kramer, S Modak, N A Kernan, L M Reich, K Danis and N-KV Cheung
Bone Marrow Transplant 37: 271-276; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705253
Stem Cell Procurement
ESHAP+fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients
S Akhtar, A Tbakhi, H Humaidan, A El Weshi, M Rahal and I Maghfoor
Bone Marrow Transplant 37: 277-282; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705239
Autografting
The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL)
F Morabito, C Stelitano, S Luminari, C Mammi, L Marcheselli, V Callea, M Gentile, G Polimeno, F Merli, S Molica, P Gobbi, F Angrilli, M Brugiatelli and M Federico
Bone Marrow Transplant 37: 283-288; advance online publication, December 5, 2005; doi:10.1038/sj.bmt.1705235
Post-Transplant Events
Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation
Y Atsuta, R Suzuki, K Yamamoto, S Terakura, H Iida, A Kohno, T Naoe, K Yano, A Wakita, H Taji, M Hamaguchi, Y Kodera, H Sao, Y Morishima, N Hamajima and Y Morishita
Bone Marrow Transplant 37: 289-296; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705247
Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes
U F Hartwig, M Nonn, S Khan, R G Meyer, C Huber and W Herr
Bone Marrow Transplant 37: 297-305; advance online publication, December 5, 2005; doi:10.1038/sj.bmt.1705238
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning
J Kline, D A Pollyea, W Stock, A Artz, E Rich, L Godley, T Zimmerman, K Thompson, K Pursell, R A Larson and K van Besien
Bone Marrow Transplant 37: 307-310; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705249
Graft-Versus-Tumor Effects
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer
M Bregni, K Fleischhauer, M Bernardi, A Pescarollo, E Guggiari, F Lunghi, S Deola, S Scaramuzza, F Re, E Setola, M Monari, B Mazzi, P Servida, P Corradini and J Peccatori
Bone Marrow Transplant 37: 311-315; advance online publication, January 9, 2006; doi:10.1038/sj.bmt.1705248
Graft-Versus-Host Disease
NK026680, a novel compound suppressive of dendritic cell function, ameliorates mortality in acute lethal graft-versus-host reaction in mice
K Saiga, E Toyoda, K Tokunaka, A Masuda, S Matsumoto, H Mashiba, H Kuramochi, K Nemoto, F Abe, N Kawagishi, H Furukawa and M Ono
Bone Marrow Transplant 37: 317-323; advance online publication, November 21, 2005; doi:10.1038/sj.bmt.1705231
Letters to the Editor
The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products
S Ciurea, R Beri, L Dobogai, S Chunduri, N Mahmud, D Rondelli and D Peace
Bone Marrow Transplant 37: 325-327; advance online publication, November 28, 2005; doi:10.1038/sj.bmt.1705223
Successful autologous peripheral blood stem cell harvest and transplant in a patient with cold agglutinins
H Crowther, D Collins, V Antonenas, M McGurgan, I Kerridge, D Gottlieb and K Bradstock
Bone Marrow Transplant 37: 329-330; advance online publication, November 21, 2005; doi:10.1038/sj.bmt.1705232
Pre-emptive granulocyte transfusions enable allogeneic hematopoietic stem cell transplantation in pediatric patients with chronic infections
R F Sharon, M Bierings, H Vrielink, B Versluys and J J Boelens
Bone Marrow Transplant 37: 331-333; advance online publication, November 28, 2005; doi:10.1038/sj.bmt.1705233
Can intra-osseous transplantation improve results of umbilical cord blood transplantation in adult patients?
S Z A Zaidi, E A Sahovic, A S Al-Shanqeeti and M Aljurf
Bone Marrow Transplant 37: 335; advance online publication, November 28, 2005; doi:10.1038/sj.bmt.1705237
Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy
J Mateos, J A Pérez-Simón, D Caballero, C Castilla, O Lopez, E Perez, C Cañizo, L Vazquez and J F San Miguel
Bone Marrow Transplant 37: 337-338; advance online publication, December 12, 2005; doi:10.1038/sj.bmt.1705241